Concussion

Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment

World-renowned brain treatment center is teaming up with a Tampa-based nonprofit to bring hyperbaric oxygen therapy treatments for Veterans across…

6 months ago

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal…

6 months ago

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),…

6 months ago

PreveCeutical Announces Date for Annual General and Special Meeting

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),…

6 months ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

– Research supports combined use of EEG/ERP and vMRI for accurate differential diagnosis of SCD, MCI and dementia – –…

6 months ago

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a…

7 months ago

Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

PreveCeutical Announces Date for Annual General and Special Meeting

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies